Work

Faculty Opinions recommendation of Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

Year: 2019

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.735124171.793565217

Author: Scott Kaufmann

Institution: Mayo Clinic

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4242022605

Cites:

Cited by: 3

Related to: 10